Can-Fite BioPharma Ltd. buy Lokrim
Start price
22.02.21
/
20%
€21.80
Target price
22.02.22
-
Performance (%)
-46.79%
End price
14.11.21
€11.60
Summary
This prediction ended on 14.11.21 with a price of €11.60. The BUY prediction by Lokrim for Can-Fite BioPharma Ltd. performed very badly with a performance of -46.79%. Lokrim has 20% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y | 3y |
---|---|---|---|---|
Can-Fite BioPharma Ltd. | - | - | - | - |
iShares Core DAX® | 2.594% | -1.158% | 14.782% | 16.813% |
iShares Nasdaq 100 | 3.553% | -1.727% | 43.265% | 44.227% |
iShares Nikkei 225® | 0.687% | -8.354% | 18.454% | 1.361% |
iShares S&P 500 | 2.209% | -0.942% | 31.361% | 42.812% |
According to Lokrim what are the pros and cons of Can-Fite BioPharma Ltd. for the foreseeable future?
Pros
Cons
Probably not worthwhile Investment
Comments by Lokrim for this prediction
In the thread Can-fite Biopharma Ltd. diskutieren
Buy Can-fite Biopharma Ltd.
In the thread Trading Can-fite Biopharma Ltd.
Buy beendet
Stopped prediction by Lokrim for Can-Fite BioPharma Ltd.
Can-Fite BioPharma Ltd.
Start price
Target price
Perf. (%)
€11.60
14.11.21
14.11.21
-
14.11.22
14.11.22
-33.62%
15.11.22
15.11.22
Probably not worthwhile Investment